Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L J Ransone

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Retinoic acid is a negative regulator of AP-1-responsive genesR Schüle, P Rangarajan, N Yang, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Novel inhibitors of AP-1 and NF-kappaB mediated gene expression: structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)++ +pyrimidi ne-5-carboxylateM S Palanki, P E Erdman, A M Manning, et al.
Nature|September 30, 1993
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa BL D Kerr, L J Ransone, P Wamsley, et al.
Transplantation Proceedings|December 1, 1996
SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivoM E Goldman, L J Ransone, D W Anderson, et al.
Journal of Medicinal Chemistry|March 4, 1998
2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3',5'- bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-kappa B- and AP-1-mediated gene expression identified using solution-phase combinatorial chemistryR W Sullivan, C G Bigam, P E Erdman, et al.
Journal of Medicinal Chemistry|October 29, 2000
Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide]M S Palanki, P E Erdman, L M Gayo-Fung, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 1991
Retinoic acid is a negative regulator of AP-1-responsive genesR Schüle, P Rangarajan, N Yang, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
Novel inhibitors of AP-1 and NF-kappaB mediated gene expression: structure-activity relationship studies of ethyl 4-[(3-methyl-2,5-dioxo(3-pyrrolinyl))amino]-2-(trifluoromethyl)++ +pyrimidi ne-5-carboxylateM S Palanki, P E Erdman, A M Manning, et al.
Nature|September 30, 1993
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa BL D Kerr, L J Ransone, P Wamsley, et al.
Transplantation Proceedings|December 1, 1996
SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivoM E Goldman, L J Ransone, D W Anderson, et al.
Journal of Medicinal Chemistry|March 4, 1998
2-Chloro-4-(trifluoromethyl)pyrimidine-5-N-(3',5'- bis(trifluoromethyl)phenyl)-carboxamide: a potent inhibitor of NF-kappa B- and AP-1-mediated gene expression identified using solution-phase combinatorial chemistryR W Sullivan, C G Bigam, P E Erdman, et al.
Journal of Medicinal Chemistry|October 29, 2000
Inhibitors of NF-kappaB and AP-1 gene expression: SAR studies on the pyrimidine portion of 2-chloro-4-trifluoromethylpyrimidine-5-[N-(3', 5'-bis(trifluoromethyl)phenyl)carboxamide]M S Palanki, P E Erdman, L M Gayo-Fung, et al.
Pageof 3